In Vitro Diagnostic Industry in China - POCT X

1.4 Blood and Electrolytes/Coagulation

The boundaries between the POCT and laboratory-based systems for blood and electrolyte testing are somewhat blurred, and instruments can be used in multiple scenarios. The global blood and electrolyte market was $1.9 billion in 2024, and is expected to exhibit growth at a CAGR of 5.2% from 2025 to 2034. In the coagulation field, the global POCT coagulation test market in 2024 was $2.8 billion. Routine blood tests and other non-life-threatening assessments are limited because of lockdowns, limited doctor/patient access, and patients’ reluctance to seek medical treatment. Market growth is expected to be driven by the increased use of automated hematology instruments, increased penetration of the POCT testing market, and the introduction of innovative hematology instruments. However, market growth has slowed over the past few years because of economic difficulties in Europe and the highly cost-conscious US market.

Last: In Vitro Diagnostic Industry in China - POCT IX